SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bafna Pharmaceuticals informs about board meeting

15 May 2013 Evaluate

Bafna Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on May 20, 2013, to consider and approve Audited Financial Results of the Company for the year ended March 31, 2013 on Standalone and Consolidated basis and to recommend payment of dividend, if any.

Further, the board to consider re-appointment of Bafna Mahaveer Chand as Chairman and Managing Director and Paras Bafna as Whole Time Director.

The above information is a part of company’s filings submitted to BSE.

Bafna Pharma Share Price

137.90 -7.10 (-4.90%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×